Target intelligence / Profile preview

Transmembrane protein 183A pseudogene 4 (TMEM183AP4)

Target: TMEM183AP4
Molecular classification: Other (Pseudogene)

Overview

TMEM183A pseudogene 4 (TMEM183AP4) is classified as a pseudogene in the human genome, meaning it is a DNA sequence that resembles a known gene but has lost its protein-coding potential and is typically nonfunctional[2][5][6]. Pseudogenes like TMEM183AP4 may occasionally be transcribed into RNA but generally do not generate functional proteins or serve as direct therapeutic targets. Most pseudogenes do not have established biological functions, and there is currently no evidence linking TMEM183AP4 to any diseases, drug interactions, or biomarker roles[2][5][6].

Other names: TMEM183AP4Transmembrane protein 183A pseudogene 4TMEM183A pseudogene 4

Beyond the preview

Go deeper on Transmembrane protein 183A pseudogene 4 (TMEM183AP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 183A pseudogene 4 (TMEM183AP4).

Explore the full profile